BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 19485800)

  • 1. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E; Faraci M
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteremias in children receiving hemopoietic SCT.
    Castagnola E; Faraci M; Moroni C; Bandettini R; Caruso S; Bagnasco F; Caviglia I; Natalizia AR; de Fazio V; Morreale G; Lanino E; Dini G; Haupt R
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S104-6. PubMed ID: 18545230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
    Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
    Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
    Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience.
    Castagnola E; Bagnasco F; Faraci M; Caviglia I; Caruso S; Cappelli B; Moroni C; Morreale G; Timitilli A; Tripodi G; Lanino E; Haupt R
    Bone Marrow Transplant; 2008 Feb; 41(4):339-47. PubMed ID: 18026151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
    Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
    Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
    Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
    Kersun LS; Propert KJ; Lautenbach E; Bunin N; Demichele A
    Pediatr Blood Cancer; 2005 Aug; 45(2):162-9. PubMed ID: 15593235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D; Depestel DD; Carver PL
    Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major complications following hematopoietic stem cell transplantation.
    Afessa B; Peters SG
    Semin Respir Crit Care Med; 2006 Jun; 27(3):297-309. PubMed ID: 16791762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of the area over the neutrophil curve index to predict early infection in hematopoietic stem cell transplantation recipients.
    Kimura S; Oshima K; Sato K; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Nishida J; Kanda Y
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1355-61. PubMed ID: 20457267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
    Girmenia C; Bertaina A; Piciocchi A; Perruccio K; Algarotti A; Busca A; Cattaneo C; Raiola AM; Guidi S; Iori AP; Candoni A; Irrera G; Milone G; Marcacci G; Scimè R; Musso M; Cudillo L; Sica S; Castagna L; Corradini P; Marchesi F; Pastore D; Alessandrino EP; Annaloro C; Ciceri F; Santarone S; Nassi L; Farina C; Viscoli C; Rossolini GM; Bonifazi F; Rambaldi A;
    Clin Infect Dis; 2017 Nov; 65(11):1884-1896. PubMed ID: 29020286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
    Toor AA; van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.